CA2389057A1 - Procedes permettant d'ameliorer les titres de vecteur viraux et de reduire la mort cellulaire dans des cultures cellulaires - Google Patents

Procedes permettant d'ameliorer les titres de vecteur viraux et de reduire la mort cellulaire dans des cultures cellulaires Download PDF

Info

Publication number
CA2389057A1
CA2389057A1 CA002389057A CA2389057A CA2389057A1 CA 2389057 A1 CA2389057 A1 CA 2389057A1 CA 002389057 A CA002389057 A CA 002389057A CA 2389057 A CA2389057 A CA 2389057A CA 2389057 A1 CA2389057 A1 CA 2389057A1
Authority
CA
Canada
Prior art keywords
composition
amino acids
serum
metal salt
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002389057A
Other languages
English (en)
Inventor
Manish Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of CA2389057A1 publication Critical patent/CA2389057A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36141—Use of virus, viral particle or viral elements as a vector
    • C12N2770/36143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des compositions et des procédés permettant d'augmenter la production d'un vecteur viral de recombinaison dans une culture cellulaire, consistant à réaliser une culture d'un vecteur viral de recombinaison produisant une ligne cellulaire dans un milieu basal qui comprend (a) plus de 1,5 g/L d'acides aminés (ou, une quantité d'un acide aminé sélectionné, par exemple un DMEM, supérieure à celle contenue dans le milieu basal), et (b) entre 0,5 % et 4 % de sérum, de manière à produire les vecteurs viraux de recombinaison.
CA002389057A 1999-10-29 2000-10-27 Procedes permettant d'ameliorer les titres de vecteur viraux et de reduire la mort cellulaire dans des cultures cellulaires Abandoned CA2389057A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16234699P 1999-10-29 1999-10-29
US60/162,346 1999-10-29
PCT/US2000/029549 WO2001032838A2 (fr) 1999-10-29 2000-10-27 Procedes permettant d'ameliorer les titres de vecteur viraux et de reduire la mort cellulaire dans des cultures cellulaires

Publications (1)

Publication Number Publication Date
CA2389057A1 true CA2389057A1 (fr) 2001-05-10

Family

ID=22585237

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002389057A Abandoned CA2389057A1 (fr) 1999-10-29 2000-10-27 Procedes permettant d'ameliorer les titres de vecteur viraux et de reduire la mort cellulaire dans des cultures cellulaires

Country Status (5)

Country Link
EP (1) EP1224260A2 (fr)
JP (1) JP2003513623A (fr)
AU (1) AU1346501A (fr)
CA (1) CA2389057A1 (fr)
WO (1) WO2001032838A2 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE135397T1 (de) * 1988-09-23 1996-03-15 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
JPH0856655A (ja) * 1994-08-16 1996-03-05 Frontier:Kk 細胞致死剤および細胞死抑制剤
FR2744455B1 (fr) * 1996-02-02 1998-04-24 Sanofi Sa Nouvelles sequences d'acides nucleiques de la famille des facteurs suppresseurs de tumeurs, produits d'expression correspondants et leurs applications

Also Published As

Publication number Publication date
WO2001032838A2 (fr) 2001-05-10
JP2003513623A (ja) 2003-04-15
EP1224260A2 (fr) 2002-07-24
WO2001032838A3 (fr) 2002-01-17
AU1346501A (en) 2001-05-14

Similar Documents

Publication Publication Date Title
Li et al. Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9
TWI239352B (en) Gene transfer method with the use of serum-free medium
CN107405411A (zh) 使用腺病毒载体的体内基因改造
JP2013165736A (ja) ウイルス産生プロセス
AU3094801A (en) Expansion of stem and progenitor cells by beta-catenin
WO2022143623A1 (fr) Souche de cellule hek293t ayant une dispersibilité élevée et son procédé de criblage
CN106497952A (zh) 一种基于cd86的膜固定蛋白、其制备方法及应用
Totsugawa et al. Lentiviral transfer of the LacZ gene into human endothelial cells and human bone marrow mesenchymal stem cells
Shen et al. Kinetics of retroviral production from the amphotropic ΨCRIP murine producer cell line
US8835177B2 (en) Method for transfer of gene into fat cell or progenitor fat cell
US7485448B2 (en) Serum-free medium for producing retroviruses
CA2389057A1 (fr) Procedes permettant d'ameliorer les titres de vecteur viraux et de reduire la mort cellulaire dans des cultures cellulaires
JP4921083B2 (ja) レトロウィルス産生用無血清培地
Hertz et al. Evolution of the Sindbis virus subgenomic mRNA promoter in cultured cells
JP3517399B2 (ja) レトロウイルスベクターのための浮遊パッケージング細胞株
CN113727735A (zh) 启动子序列和相关产物及其用途
US20240018487A1 (en) Suspension mode seed train development for adherent cells
KR101174341B1 (ko) 레트로 바이러스의 보존 방법
Ketola et al. Properties of Sindbis virus vectors produced with a chimeric split helper system
Bajpai et al. Genetic manipulation of human embryonic stem cells: lentivirus vectors
KR20200101322A (ko) 진핵 세포주
Hanawa et al. 385. Development of an SIV-Based Lentiviral Vector System for Transduction of Rhesus, Primitive Hematopoietic Cells
Kathryn Electroporation for Gene Therapy Kathryn E, Matthews, Sukhendu B. Dev, Frances Toneguzzo, and Armand Keating
Oliveira Application of functional genomics in the production of viral biopharmaceuticals: Vaccines and Vectors for gene therapy
US20020164800A1 (en) Retroviral vector

Legal Events

Date Code Title Description
FZDE Discontinued